肿瘤特异性与全身影像生物标志物对III期结直肠癌患者复发预测的作用
这项前瞻性观察研究纳入101例新诊断III期结直肠癌患者,评估基线治疗前CT提取的肿瘤放射组学与身体组成形态组学特征对复发的预测价值。病理分期(HR 2.69)、术后CEA(每1 ng/mL HR 1.11)、骨密度(每1 HU HR 1.01)和肿瘤偏度(每1单位 HR 0.33)与复发相关,联合模型可将患者分为低、中、高风险。
要点
- 基线CT提取的放射组学与形态组学特征均独立与III期结直肠癌复发风险相关。
- 病理分期、术后CEA、骨密度和肿瘤偏度为多因素分析中与复发相关的因素。
- Cox回归模型可将患者分为低、中、高复发风险三层。
核心结论
- 放射组学与形态组学特征均独立与结直肠癌复发风险相关,二者联合时各自为解释复发风险提供有价值的信息。
研究设计与样本
- 前瞻性观察研究,纳入101例新诊断III期结直肠癌患者,采用基线治疗前CT提取影像特征,以复发时间为最终结局,使用单变量和多变量检验及Kaplan-Meier和log-rank检验。
诊断标准与关键数值
- 多因素分析中,病理分期HR 2.69(p=0.03)、术后CEA每1 ng/mL HR 1.11(p<0.005)、骨密度每1 Hounsfield Unit HR 1.01(p<0.01)、肿瘤偏度每1单位 HR 0.33(p<0.05)与复发相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Imaging biomarkers are emerging as non-invasive predictors of cancer prognosis and clinical outcome. We assessed tumor-specific ("radiomics") and body composition imaging features ("morphomics") extracted from baseline pre-treatment CT for prediction of recurrence in patients with stage III colorectal cancer (CRC).
METHODS: Patients with newly diagnosed stage III CRC were enrolled in this prospective observational study. Patients with available preoperative scans were included (N = 101). The tumor, if visible, was manually segmented and first-order radiomics features were extracted with a commercially available software. The morphomics features (reflecting muscle, fat, and bone characteristics) were extracted in a standardized fashion using a proprietary software and the values were adjusted and normalized based on a reference standard. Time to recurrence was the final outcome. Correlation between demographics, clinical features, radiomics, and morphomics features and outcome were assessed using univariate and multivariate tests as well as Kaplan-Meier and log-rank tests.
RESULTS: Morphomic analysis was performed in all 101 patients. 60 patients had discrete tumors suitable for radiomics analysis. These patients had lower ECOG score (p < 0.05), more muscle mass (p > 0.05), and lower fat density (p > 0.05) compared to the patients in whom radiomics analysis could not be performed. Pathological stage (HR: 2.69; p = 0.03), CEA level after surgery (HR: 1.11 for 1 ng/mL; p < 0.005), bone mineral density (HR: 1.01 for 1 Hounsfield Unit; p < 0.01), and tumor skewness (HR: 0.33 for 1 unit; p < 0.05) had association with recurrence based on both univariate and multivariate analyses. A model using Cox's regression analyses was able to divide the patients into low-, medium-, and high-risk for recurrence.
CONCLUSIONS: Both radiomics and morphomics features were independently associated with the risk of CRC recurrence and, when combined, each contributed valuable information to explain risk of recurrence.
TRIAL REGISTRATION: Clinical trial.gov NCT02842203. Patient recruitment occurred between 22/07/2016 and 18/03/2020.
引用
- Borhani AA, Zhang P, Diergaarde B, et al. Role of tumor-specific and whole-body imaging biomarkers for prediction of recurrence in patients with stage III colorectal cancer. Abdom Radiol (NY). 2024. PMID: 39487920. doi:10.1007/s00261-024-04656-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。